| NDC Code | 51267-890-07 |
|---|
| Package Description | 7 TABLET, EXTENDED RELEASE in 1 BOTTLE (51267-890-07) |
|---|
| Product NDC | 51267-890 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Contrave |
|---|
| Proprietary Name Suffix | Extended-release |
|---|
| Non-Proprietary Name | Naltrexone Hydrochloride And Bupropion Hydrochloride |
|---|
| Dosage Form | TABLET, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20141022 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA200063 |
|---|
| Manufacturer | Nalpropion Pharmaceuticals LLC |
|---|
| Substance Name | BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE |
|---|
| Strength | 90; 8 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA], Opioid Antagonist [EPC], Opioid Antagonists [MoA] |
|---|